[go: up one dir, main page]

AR121356A1 - Compuestos antivirales - Google Patents

Compuestos antivirales

Info

Publication number
AR121356A1
AR121356A1 ARP210100409A ARP210100409A AR121356A1 AR 121356 A1 AR121356 A1 AR 121356A1 AR P210100409 A ARP210100409 A AR P210100409A AR P210100409 A ARP210100409 A AR P210100409A AR 121356 A1 AR121356 A1 AR 121356A1
Authority
AR
Argentina
Prior art keywords
independently
alkyl
compound
optionally substituted
formula
Prior art date
Application number
ARP210100409A
Other languages
English (en)
Inventor
Daniel H Byun
Gregory F Chin
Michael Oneil Hanrahan Clarke
Bindu Goyal
Petr Jansa
Richard L Mackman
Michael R Mish
Dustin S Siegel
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of AR121356A1 publication Critical patent/AR121356A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2458—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente divulgación describe 4’-fluorometil nucleósidos para tratar infecciones virales, incluyendo el Dengue. Reivindicación 1: Un compuesto de fórmula (1), o una sal farmacéuticamente aceptable del mismo, en donde: Base es un compuesto del grupo de fórmulas (2); R¹ y R² son cada uno independientemente H o -C(O)R¹A, en donde R¹A es alquilo C₁₋₆; R³ es -N(H)R³A; R³A es H, -CH₂OP(O)(OH)₂, o -C(O)R³D, en donde R³D es arilo C₆₋₁₂ o alquilo C₁₋₆ opcionalmente sustituido con un cicloalquilo C₃₋₆; R⁴A es O; R⁴B y R⁴C son cada uno independientemente: (A) -OH; (B) -OR⁴B¹, en donde R⁴B¹ es arilo C₆₋₁₂; (C) un compuesto de fórmula (3), en donde subíndice m es 0, 1, 2, 3, 4, ó 5; y cada uno R⁴D es independientemente alquilo C₁₋₆; (D) un compuesto de fórmula (4), en donde R⁴E¹ y R⁴E² son cada uno independientemente H o alquilo C₁₋₆; R⁴F¹ y R⁴F² juntos son oxo; R⁴G es alquilo C₁₋₈ opcionalmente sustituido con 1 a 3 R⁴G¹, cicloalquilo C₃₋₈, o un heterociclilo de 3 a 8 miembros que tiene 1 a 3 heteroátomos seleccionados de N, O y S, opcionalmente sustituido con 1 a 3 R⁴G³; cada uno R⁴G¹ es independientemente -OH, alcoxi C₁₋₆, -(CH₂OCH₂)₁₋₅-CH₃, haloalquilo C₁₋₃, o cicloalquilo C₃₋₈ opcionalmente sustituido con 1 a 3 R⁴G⁹; cada uno R⁴G³ y R⁴G⁹ es independientemente alquilo C₁₋₆; o (E) -(OP(O)(OH))₁₋₂-OH; y R⁵A y R⁵B son cada uno independientemente alquilo C₁₋₆ sustituido con -OP(O)(OH)₂.
ARP210100409A 2020-02-18 2021-02-17 Compuestos antivirales AR121356A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202062978199P 2020-02-18 2020-02-18

Publications (1)

Publication Number Publication Date
AR121356A1 true AR121356A1 (es) 2022-05-11

Family

ID=74859526

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210100409A AR121356A1 (es) 2020-02-18 2021-02-17 Compuestos antivirales

Country Status (13)

Country Link
US (2) US12030903B2 (es)
EP (2) EP4644394A2 (es)
JP (2) JP7429799B2 (es)
KR (2) KR20220143064A (es)
CN (2) CN118598916A (es)
AR (1) AR121356A1 (es)
AU (2) AU2021224588B2 (es)
CA (1) CA3171648A1 (es)
ES (1) ES3052691T3 (es)
PT (1) PT4106876T (es)
SI (1) SI4106876T1 (es)
TW (1) TWI777411B (es)
WO (1) WO2021168004A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI883391B (zh) 2020-02-18 2025-05-11 美商基利科學股份有限公司 抗病毒化合物
TWI775313B (zh) 2020-02-18 2022-08-21 美商基利科學股份有限公司 抗病毒化合物
JP7688152B2 (ja) 2021-04-16 2025-06-03 ギリアード サイエンシーズ， インコーポレイテッド アミドを使用してカルバヌクレオシドを調製する方法
EP4387977A1 (en) 2021-08-18 2024-06-26 Gilead Sciences, Inc. Phospholipid compounds and methods of making and using the same
WO2024200177A1 (en) * 2023-03-24 2024-10-03 Basf Se Process for the preparation of amino acid esters as organoether sulfate salts from alkoxylated alcohols

Family Cites Families (487)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361306A (en) 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
US3565070A (en) 1969-02-28 1971-02-23 Riker Laboratories Inc Inhalation actuable aerosol dispenser
FR2224175B1 (es) 1973-04-04 1978-04-14 Isf Spa
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1017153B (it) 1974-07-15 1977-07-20 Isf Spa Apparecchio per inalazioni
NL7606413A (en) 1976-06-14 1977-12-16 Kowa Co Adenosine-5'-phosphoric acid derivs. and their salts - prepd. by acylating adenosine-5'-phosphate and opt. desalting or salt exchanging
DE2626792A1 (de) 1976-06-15 1977-12-29 Kowa Co Acylderivate von adenosin-5'-monophosphorsaeure, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
FR2354774A1 (fr) 1976-06-15 1978-01-13 Kowa Co Derives de l'acide adenosine-5'-monophosphorique et medicament contenant ces substances
SE438261B (sv) 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
US4805811A (en) 1985-03-29 1989-02-21 Aktiebolaget Draco Dosage device
SE448277B (sv) 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
JPS6286363A (ja) 1985-10-11 1987-04-20 Fuji Photo Film Co Ltd ハロゲン化銀カラ−写真感光材料
DE3528753A1 (de) 1985-08-10 1987-02-19 Bayer Ag Substituierte pyrazolin-5-one
US4707540A (en) 1986-10-29 1987-11-17 Morton Thiokol, Inc. Nitramine oxetanes and polyethers formed therefrom
US4871758A (en) 1987-03-18 1989-10-03 Schulman Jerome M Pharmacologically active cholinergic compositions, and methods for making same and use thereof in treating disease
DE3711345A1 (de) 1987-04-03 1988-10-20 Bayer Ag Substituierte propylamine
IN167775B (es) 1988-06-24 1990-12-22 Hoechst India
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
US4955371A (en) 1989-05-08 1990-09-11 Transtech Scientific, Inc. Disposable inhalation activated, aerosol device for pulmonary medicine
US5674998A (en) 1989-09-15 1997-10-07 Gensia Inc. C-4' modified adenosine kinase inhibitors
DE3932052A1 (de) 1989-09-26 1991-04-04 Basf Ag Oxazol- bzw. thiazolcarbonsaeureamide
WO1991010671A1 (en) 1990-01-11 1991-07-25 Isis Pharmaceuticals, Inc. Compositions and methods for detecting and modulating rna activity and gene expression
YU84791A (sh) 1990-05-19 1994-06-10 Boehringer Ingelheim Kg. Biciklicni 1-aza-cikloalkalni
MY106399A (en) 1990-07-24 1995-05-30 Pfizer Cephalosporins and homologeus, preparation and pharmaceutical composition
FR2669639A1 (fr) 1990-11-27 1992-05-29 Atochem Cocatalyseur de polymerisation du propylene a base de silane et de monoether.
TW239158B (es) 1991-02-15 1995-01-21 Lubrizol Corp
ES2141108T3 (es) 1991-07-02 2000-03-16 Inhale Inc Metodo y dispositivo para proporcionar medicamentos en aerosol.
GB9202791D0 (en) 1992-02-11 1992-03-25 British Bio Technology Compounds
US5261538A (en) 1992-04-21 1993-11-16 Glaxo Inc. Aerosol testing method
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
DE4232852A1 (de) 1992-09-30 1994-03-31 Bayer Ag Imidazolinyl-pyridazine
US5388572A (en) 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5446137B1 (en) 1993-12-09 1998-10-06 Behringwerke Ag Oligonucleotides containing 4'-substituted nucleotides
EP0682098B1 (en) 1994-04-14 2001-09-05 Canon Kabushiki Kaisha Liquid crystal composition, liquid crystal device and display method using the composition
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5681940A (en) 1994-11-02 1997-10-28 Icn Pharmaceuticals Sugar modified nucleosides and oligonucleotides
US5544647A (en) 1994-11-29 1996-08-13 Iep Group, Inc. Metered dose inhalator
US5622163A (en) 1994-11-29 1997-04-22 Iep Group, Inc. Counter for fluid dispensers
JP3822925B2 (ja) 1995-07-18 2006-09-20 興和株式会社 ２’−３’−ジ−ｏ−アシルａｔｐの製造法
JPH09328497A (ja) 1996-04-12 1997-12-22 Yamasa Shoyu Co Ltd ４’−フルオロメチルヌクレオシド
HUP0001186A3 (en) 1996-10-16 2002-04-29 Icn Pharmaceuticals Inc Costa Purine l-nucleosides,analogs and pharmaceutical compositions thereof
UA63956C2 (uk) 1997-06-30 2004-02-16 Ай-Сі-Ен Фармасьютикалз, Інк. Спосіб одержання нуклеозидів
AU9063398A (en) 1997-09-12 1999-04-05 Exiqon A/S Oligonucleotide analogues
US6150379A (en) 1997-11-26 2000-11-21 Axys Pharmaceuticals, Inc. Compounds and compositions as anticoagulants
AU1608399A (en) 1997-11-26 1999-06-15 Axys Pharmaceuticals, Inc. Substituted amidinoaryl derivatives and their use as anticoagulants
US5972099A (en) 1997-12-17 1999-10-26 Bayer Corporation Process for preparing organic pigment compositions
WO2002007516A2 (en) 2000-07-14 2002-01-31 The Uab Research Foundation Uses for nad synthetase inhibitors
CO5040088A1 (es) 1998-04-03 2001-05-29 Advanced Medicine Inc Nuevos compuestos y usos anestesicos locales
AU4322799A (en) 1998-05-28 1999-12-13 Incara Pharmaceuticals Corp. Carbohydrate-based scaffold compounds, combinatorial libraries and methods for their construction
AU4966199A (en) 1998-07-03 2000-01-24 Millennium Pharmaceuticals, Inc. Substituted oxygen alicyclic compounds, including methods for synthesis thereof
WO2000032152A2 (en) 1998-12-02 2000-06-08 Princeton University Compositions and methods for regulating bacterial pathogenesis
US6432975B1 (en) 1998-12-11 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
US6116234A (en) 1999-02-01 2000-09-12 Iep Pharmaceutical Devices Inc. Metered dose inhaler agitator
GB9908934D0 (en) 1999-04-19 1999-06-16 Rolic Ag Liquid crystalline compounds
EP1046631A1 (en) 1999-04-19 2000-10-25 Rolic AG Liquid crystalline compounds
DK1178999T3 (da) 1999-05-04 2007-08-06 Santaris Pharma As L-RIBO-LNA-analoger
AUPQ105499A0 (en) 1999-06-18 1999-07-08 Biota Scientific Management Pty Ltd Antiviral agents
BR0012135A (pt) 1999-06-29 2002-07-02 Uab Research Foundation Métodos de tratamento de infecções de fungos com inibidores de enzima sintetase nad
DE19934799B4 (de) 1999-07-28 2008-01-24 Az Electronic Materials (Germany) Gmbh Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten
WO2001010842A2 (en) 1999-08-04 2001-02-15 Millennium Pharmaceuticals, Inc. Melanocortin-4 receptor binding compounds and methods of use thereof
DE19939910A1 (de) 1999-08-23 2001-03-01 Morphochem Ag Neue Verbindungen, die Tryptase-Aktivität hemmen
WO2001019841A1 (en) 1999-09-17 2001-03-22 Amersham Pharmacia Biotech, Inc. Charge-modified nucleic acid terminators
AU7315700A (en) 1999-09-20 2001-04-24 Takeda Chemical Industries Ltd. Melanin concentrating hormone antagonist
US6514964B1 (en) 1999-09-27 2003-02-04 Amgen Inc. Fused cycloheptane and fused azacycloheptane compounds and their methods of use
GB9930557D0 (en) 1999-12-23 2000-02-16 Rolic Ag Optically active materials
WO2001064643A2 (en) 2000-02-29 2001-09-07 Cor Therapeutics, Inc. BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
US20090124690A1 (en) 2000-04-03 2009-05-14 Alberte Randall S Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins
AU2001253206A1 (en) 2000-04-05 2001-10-23 Tularik, Inc. Ns5b hcv polymerase inhibitors
US6696081B2 (en) 2000-06-09 2004-02-24 Duke University Carbohydrate based lipid compositions and supramolecular structures comprising same
EP1170353B1 (en) 2000-07-06 2005-11-02 Fuji Photo Film Co., Ltd. Liquid crystal composition comprising liquid crystal molecules and aligment promoter
AU2001279955A1 (en) 2000-08-18 2002-03-04 Sterix Limited 2-substituted estradiol derivative for inhibiting superoxid dismutase
AU2001294865A1 (en) 2000-09-30 2002-04-15 Loctite Low shrinkage thermosetting resin compositions and methods of use therefor
WO2002034711A1 (en) 2000-10-20 2002-05-02 Biocryst Pharmaceuticals, Inc. Biaryl compounds as serine protease inhibitors
AUPR105700A0 (en) 2000-10-27 2000-11-23 Monash University Process for preparation of bicyclic and polycyclic molecules
WO2002039987A2 (en) 2000-11-14 2002-05-23 Neurosearch A/S Use of malaria parasite anion channel blockers for treating malaria
AUPR213700A0 (en) 2000-12-18 2001-01-25 Biota Scientific Management Pty Ltd Antiviral agents
DE10064823A1 (de) 2000-12-22 2002-06-27 Knoll Ag Integrinrezeptorliganden
EP1363890A4 (en) 2001-02-07 2009-06-10 Ore Pharmaceuticals Inc MELANOCORTIN-4-RECEPTOR BINDING COMPOUNDS AND METHOD FOR THEIR APPLICATION
JP2002326996A (ja) 2001-03-02 2002-11-15 Toray Ind Inc 光学活性体の製造法
JP4161291B2 (ja) 2001-03-02 2008-10-08 東レ・ファインケミカル株式会社 光学活性体の製造法
ATE438615T1 (de) 2001-04-06 2009-08-15 Biocryst Pharm Inc Biarylverbindungen als serinproteaseinhibitoren
US20030175950A1 (en) 2001-05-29 2003-09-18 Mcswiggen James A. RNA interference mediated inhibition of HIV gene expression using short interfering RNA
US20030170891A1 (en) 2001-06-06 2003-09-11 Mcswiggen James A. RNA interference mediated inhibition of epidermal growth factor receptor gene expression using short interfering nucleic acid (siNA)
EP2415486B1 (en) 2001-05-18 2017-02-22 Sirna Therapeutics, Inc. Conjugates and compositions for cellular delivery
GB0114286D0 (en) 2001-06-12 2001-08-01 Hoffmann La Roche Nucleoside Derivatives
JP2005538183A (ja) 2001-09-13 2005-12-15 ジーンソフト ファーマシューティカルズ インコーポレイテッド 薬剤耐性細菌による感染症の治療方法
AU2002351077A1 (en) 2001-11-05 2003-05-19 Exiqon A/S Oligonucleotides modified with novel alpha-l-rna analogues
EP1446115B1 (en) 2001-11-13 2008-02-27 Merck Frosst Canada Ltd. Cyanoalkylamino derivatives as protease inhibitors
JP2005538035A (ja) 2001-12-11 2005-12-15 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ グアニジニウム輸送試薬および結合体
JP2003246770A (ja) 2002-02-25 2003-09-02 Toray Ind Inc 光学活性体の製造法
TW200403058A (en) 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
CA2483192A1 (en) 2002-04-24 2003-11-06 Symyx Technologies, Inc. Bridged bi-aromatic ligands, complexes, catalysts and processes for polymerizing and poymers therefrom
EP1498125A4 (en) 2002-04-24 2008-08-20 Takeda Pharmaceutical USE OF COMPOUNDS WITH CCR ANTAGONISM
CN104193791A (zh) 2002-06-28 2014-12-10 埃迪尼克斯医药公司 用于治疗黄病毒感染的修饰的2’和3’-核苷前药
US20060004010A1 (en) 2002-07-10 2006-01-05 Hiromu Habashita Ccr4 antagonist and medical use thereof
WO2004014312A2 (en) 2002-08-08 2004-02-19 Sirna Therapeutics, Inc. Small-mer compositions and methods of use
WO2004037159A2 (en) 2002-10-23 2004-05-06 Obetherapy Biotechnology Compounds, compositions and methods for modulating fat metabolism
US20040229840A1 (en) 2002-10-29 2004-11-18 Balkrishen Bhat Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
US20040146941A1 (en) 2002-11-04 2004-07-29 Biliang Zhang Chemical encoding technology for combinatorial synthesis
US7329658B2 (en) 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
US7176210B2 (en) 2003-02-10 2007-02-13 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
WO2004080966A1 (ja) 2003-03-14 2004-09-23 Ono Pharmaceutical Co., Ltd. 含窒素複素環誘導体およびそれらを有効成分とする薬剤
US7135469B2 (en) 2003-03-18 2006-11-14 Bristol Myers Squibb, Co. Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
GB0306430D0 (en) 2003-03-20 2003-04-23 Bp Chem Int Ltd Polymerisation and oligomerisation catalysts
EP2258365B1 (en) 2003-03-28 2013-05-29 Novartis Vaccines and Diagnostics, Inc. Use of organic compounds for immunopotentiation
EP1613261A4 (en) 2003-04-09 2011-01-26 Novo Nordisk As INTRA-CELLULAR FORMATION OF PEPTIDE CONJUGATES
JP2004315613A (ja) 2003-04-14 2004-11-11 Fuji Photo Film Co Ltd セルロースアシレートフィルム、その製造方法、偏光板保護膜、液晶表示装置、及びハロゲン化銀写真感光材料
US7268133B2 (en) 2003-04-23 2007-09-11 Pfizer, Inc. Patent Department Cannabinoid receptor ligands and uses thereof
BRPI0410348A (pt) 2003-05-14 2006-05-30 Torreypines Therapeutics Inc compostos e usos dos mesmos na modulação de amilóide-beta
US20040229839A1 (en) 2003-05-14 2004-11-18 Biocryst Pharmaceuticals, Inc. Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
WO2005020885A2 (en) 2003-05-21 2005-03-10 Isis Pharmaceuticals, Inc. Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
WO2004106356A1 (en) 2003-05-27 2004-12-09 Syddansk Universitet Functionalized nucleotide derivatives
ES2355565T3 (es) 2003-08-27 2011-03-29 Biota Scientific Management Pty. Ltd. Nuevos nucleósidos o nucleótidos tricíclos como agentes terapéuticos.
EP1661889A4 (en) 2003-09-05 2009-08-05 Ono Pharmaceutical Co ANTAGONIST OF THE CHEMOKINE RECEPTOR AND ITS USE FOR MEDICAL PURPOSES
US20050203063A1 (en) 2003-09-12 2005-09-15 Raymond Deshaies Proteasome pathway inhibitors and related methods
JP4231379B2 (ja) 2003-10-15 2009-02-25 富士フイルム株式会社 潤滑剤組成物
US20070099938A1 (en) 2003-10-24 2007-05-03 Ono Pharmaceutical Co., Ltd. Antistress drug and medical use thereof
WO2005058832A1 (en) 2003-12-10 2005-06-30 Merck Patent Gmbh Diacylhydrazine derivatives
WO2005095544A1 (en) 2004-03-25 2005-10-13 Merck Patent Gmbh Liquid crystal compounds, liquid crystal medium and liquid crystal display
WO2005093476A1 (en) 2004-03-25 2005-10-06 Fuji Photo Film Co., Ltd. Transparent film and optical compensatory film, polarizing plate and liquid-crystal display device employing it
US7306631B2 (en) 2004-03-30 2007-12-11 The Procter & Gamble Company Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
EP1593713A1 (en) 2004-05-04 2005-11-09 Rolic AG Polymerizable dichromophoric dichroic azo dyes
GB0410604D0 (en) 2004-05-12 2004-06-16 Bp Chem Int Ltd Ethylene copolymers
JP5315611B2 (ja) 2004-06-23 2013-10-16 小野薬品工業株式会社 Ｓ１ｐ受容体結合能を有する化合物およびその用途
WO2006006490A1 (ja) 2004-07-08 2006-01-19 Ono Pharmaceutical Co., Ltd. スピロ化合物
GB0415879D0 (en) 2004-07-15 2004-08-18 Bp Chem Int Ltd Polymerisation catalyst
GB0418022D0 (en) 2004-08-12 2004-09-15 Bp Chem Int Ltd Polymerisation and oligomerisation catalyst
GB0420396D0 (en) 2004-09-14 2004-10-13 Bp Chem Int Ltd Polyolefins
WO2006038594A1 (ja) 2004-10-04 2006-04-13 Ono Pharmaceutical Co., Ltd. Ｎ型カルシウムチャネル阻害薬
GB0424422D0 (en) 2004-11-04 2004-12-08 Bp Chem Int Ltd Polymerisation catalysts
JP4429149B2 (ja) 2004-11-26 2010-03-10 キヤノン株式会社 フルオレン化合物及び有機発光素子
WO2006061094A1 (en) 2004-12-11 2006-06-15 Merck Patent Gmbh Liquid crystal compounds, liquid crystal medium and liquid crystal display
WO2006066074A2 (en) 2004-12-16 2006-06-22 The Regents Of The University Of California Lung-targeted drugs
EP1828217A2 (en) 2004-12-16 2007-09-05 Febit Biotech GmbH Polymerase-independent analysis of the sequence of polynucleotides
JP4749000B2 (ja) 2005-02-22 2011-08-17 富士フイルム株式会社 グリース組成物
US7622240B2 (en) 2005-02-28 2009-11-24 International Business Machines Corporation Low blur molecular resist
EP1858889A1 (en) 2005-03-08 2007-11-28 Biota Scientific Management Pty. Ltd. Bicyclic nucleosides and nucleotides as therapeutic agents
WO2006098380A1 (ja) 2005-03-15 2006-09-21 Fujifilm Corporation 円盤状化合物を用いた表面処理法、表面処理用（潤滑）組成物及び表面処理された物品
CA2610854A1 (en) 2005-03-30 2006-10-05 Sirtris Pharmaceuticals, Inc. Nicotinamide riboside and analogues thereof
US20090156545A1 (en) 2005-04-01 2009-06-18 Hostetler Karl Y Substituted Phosphate Esters of Nucleoside Phosphonates
WO2006110656A2 (en) 2005-04-08 2006-10-19 Chimerix, Inc. Compounds, compositions and methods for the treatment of viral infections and other medical disorders
EP1883687A1 (en) 2005-05-09 2008-02-06 Technische Universität Braunschweig Light emitting compound for electroluminescent applications
US7576205B2 (en) 2005-06-13 2009-08-18 Agency For Science, Technology & Research Detectable threading intercalator
WO2007007588A1 (ja) 2005-07-08 2007-01-18 Ono Pharmaceutical Co., Ltd. 平面性を有する環状基を母核とする化合物
WO2007011759A2 (en) 2005-07-15 2007-01-25 Kalypsys, Inc. Inhibitors of mitotic kinesin
JP2007056213A (ja) 2005-08-26 2007-03-08 Fujifilm Corp 焼結含油軸受油用組成物、並びにそれを用いた軸受け装置及び摺動部材
DE102005043165A1 (de) 2005-09-12 2007-03-22 Merck Patent Gmbh Metallkomplexe
US20070219192A1 (en) 2005-11-02 2007-09-20 Xiangping Qian Certain chemical entities, compositions, and methods
JP5116687B2 (ja) 2005-11-02 2013-01-09 バイエル・ファルマ・アクチェンゲゼルシャフト がんおよび他の過剰増殖性疾患の処置のためのピロロ［２，１−ｆ］［１，２，４］トリアジン−４−イルアミンＩＧＦ−１Ｒキナーゼ阻害剤
US7910595B2 (en) 2005-12-21 2011-03-22 Abbott Laboratories Anti-viral compounds
CA2635899A1 (en) 2006-01-19 2007-07-26 Osi Pharmaceuticals, Inc. Fused heterobicyclic kinase inhibitors
US7622463B2 (en) 2006-02-14 2009-11-24 Vertex Pharmaceuticals Incorporated Dihydrodiazepines useful as inhibitors of protein kinases
CA2647933A1 (en) 2006-03-29 2007-11-08 Schering Corporation Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
US20090124610A1 (en) 2006-04-25 2009-05-14 Gordon Saxty Pharmaceutical compounds
US7749983B2 (en) 2006-05-03 2010-07-06 Chimerix, Inc. Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
WO2008001195A2 (en) 2006-06-27 2008-01-03 Glenmark Pharmaceuticals S.A. Novel processes for the preparation of dpp iv inhibitors
JP2008007634A (ja) 2006-06-29 2008-01-17 Fujifilm Corp 潤滑剤組成物
US20080021217A1 (en) 2006-07-20 2008-01-24 Allen Borchardt Heterocyclic inhibitors of rho kinase
GB0614947D0 (en) 2006-07-27 2006-09-06 Isis Innovation Epitope reduction therapy
PE20080906A1 (es) 2006-08-17 2008-07-05 Kemia Inc Derivados heteroarilo como inhibidores de citocina
RU2009101298A (ru) 2006-08-22 2010-09-27 Рэдпойнт Био Корпорэйшн (Us) Гетероциклические соединения в качестве усилителей подслащивающего вещества
US20080261913A1 (en) 2006-12-28 2008-10-23 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of liver disorders
HRP20120758T1 (hr) 2007-01-12 2012-10-31 Biocryst Pharmaceuticals, Inc. Antiviralni nukleozidni analozi
WO2008092006A2 (en) 2007-01-24 2008-07-31 Cernofina, Llc Antimicrobial compositions
WO2008095040A2 (en) 2007-01-31 2008-08-07 Alios Biopharma, Inc. 2-5a derivatives and their use as anti-cancer, anti-viral and anti-parasitic agents
CA2680312A1 (en) 2007-03-07 2008-09-12 Alantos Pharmaceuticals Holding, Inc. Metalloprotease inhibitors containing a heterocyclic moiety
US8088566B2 (en) 2007-03-26 2012-01-03 Fujifilm Corporation Surface-treating agent for pattern formation and pattern-forming method using the surface-treating agent
WO2008117047A1 (en) 2007-03-27 2008-10-02 Astrazeneca Ab Pyrazolo[3, 4-d]pyrimidine derivatives as antibacterial compounds
US7956020B2 (en) 2007-03-29 2011-06-07 Fujifilm Corporation Lubricant composition, mechanical element, and method for producing triazine derivatives
US8088940B2 (en) 2007-03-30 2012-01-03 Momentive Performance Materials Inc. Hydrolyzable silanes of low VOC-generating potential and resinous compositions containing same
JP2010525063A (ja) 2007-04-27 2010-07-22 キメリクス，インコーポレイテッド ヌクレオシドホスホナートが投与された被験者における腎毒性を減少させる方法
WO2008141079A1 (en) 2007-05-10 2008-11-20 Biocryst Pharmaceuticals, Inc. Tetrahydrofuro [3 4-d] dioxolane compounds for use in the treatment of viral infections and cancer
US20110319459A1 (en) 2007-06-14 2011-12-29 Osta Biotechnologies Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System
CA2727528A1 (en) 2007-06-14 2008-12-18 Osta Biotechnologies Heme-oxygenase inhibitors and use of the same in the treatment of cancer and diseases of the central nervous system
GB0712494D0 (en) 2007-06-27 2007-08-08 Isis Innovation Substrate reduction therapy
CN100532388C (zh) 2007-07-16 2009-08-26 郑州大学 2’-氟-4’-取代-核苷类似物、其制备方法及应用
CN101679682B (zh) 2007-07-19 2012-06-13 柯尼卡美能达精密光学株式会社 纤维素酯膜、纤维素酯膜的制造方法、使用该纤维素酯膜的偏振片保护膜、偏振片以及液晶显示装置
KR101526024B1 (ko) 2007-07-19 2015-06-04 코니카 미놀타 어드밴스드 레이어즈 인코포레이티드 셀룰로오스 에스테르 필름, 셀룰로오스 에스테르 필름의 제조 방법, 그것을 사용한 편광판 및 액정 표시 장치
US9340506B2 (en) 2007-10-08 2016-05-17 Advinus Therapeutics Limited Acetamide derivatives as glucokinase activators, their process and medicinal applications
US20090318380A1 (en) 2007-11-20 2009-12-24 Pharmasset, Inc. 2',4'-substituted nucleosides as antiviral agents
CL2008003511A1 (es) 2007-11-29 2010-02-19 Metabasis Therapeutics Inc Compuestos derivados nucleotidicos, inhibidores de polimerasa ns5b del virus de la hepatitis c; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c.
NZ586271A (en) 2007-12-13 2012-08-31 Vertex Pharma Fused pyrimidinone derivatives as modulators of cystic fibrosis transmembrane conductance regulator
WO2009086201A1 (en) 2007-12-21 2009-07-09 Alios Biopharma, Inc. 2-5a analogs and their use as anti-cancer, anti-viral and anti- paras iti c agents
WO2009086192A1 (en) 2007-12-21 2009-07-09 Alios Biopharma, Inc. Biodegradable phosphate protected nucleotide derivatives and their use as cancer, anti viral and anti parasitic agents
TW200942243A (en) 2008-03-05 2009-10-16 Biocryst Pharm Inc Antiviral therapeutic agents
EP2098226A1 (de) 2008-03-06 2009-09-09 Forschungsverbund Berlin e.V. AKAP-PKA-Interaktionshemmer zur Anwendung in der Behandlung von Herzkrankheiten
US8012941B2 (en) 2008-04-23 2011-09-06 Gilead Sciences, Inc. Carba-nucleoside analogs for antiviral treatment
WO2010036407A2 (en) 2008-05-15 2010-04-01 Biocryst Pharmaceuticals, Inc. Antiviral nucleoside analogs
AU2009257815B2 (en) 2008-05-27 2014-05-29 Trilink Biotechnologies Chemically modified nucleoside 5'-triphosphates for thermally initiated amplification of nucleic acid
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
US7910019B2 (en) 2008-06-27 2011-03-22 Transitions Optical, Inc. Mesogen containing compounds
US8628685B2 (en) 2008-06-27 2014-01-14 Transitions Optical, Inc Mesogen-containing compounds
US7910020B2 (en) 2008-06-27 2011-03-22 Transitions Optical, Inc. Liquid crystal compositions comprising mesogen containing compounds
US7803285B2 (en) 2008-07-01 2010-09-28 Gentex Corporation Liquid crystal display device and associated liquid crystal media for use in the same
EP2313102A2 (en) 2008-07-03 2011-04-27 Biota Scientific Management Bycyclic nucleosides and nucleotides as therapeutic agents
GB0812297D0 (en) 2008-07-04 2008-08-13 Lucite Int Uk Ltd Novel carbonylation ligand sand thier use of in the carbonylation of ethylenically unsaturated compounds
UY31982A (es) 2008-07-16 2010-02-26 Boehringer Ingelheim Int Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas
GB0815968D0 (en) 2008-09-03 2008-10-08 Angeletti P Ist Richerche Bio Antiviral agents
JP5295692B2 (ja) 2008-09-10 2013-09-18 豊和工業株式会社 自動開閉防音サッシ
US8962580B2 (en) 2008-09-23 2015-02-24 Alnylam Pharmaceuticals, Inc. Chemical modifications of monomers and oligonucleotides with cycloaddition
US20100096603A1 (en) 2008-10-20 2010-04-22 Nitto Denko Corporation Optical devices responsive to near infrared laser and methods of modulating light
US20120165304A1 (en) 2008-11-27 2012-06-28 Boehringer Ingelheim International Gmbh 6,7,8,9-Tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
WO2010073126A2 (en) 2008-12-22 2010-07-01 The Governors Of The University Of Alberta Compounds useful in delivering anti-neoplastic therapy and diagnostic imaging to hypoxic cells and methods of use thereof
GB0900914D0 (en) 2009-01-20 2009-03-04 Angeletti P Ist Richerche Bio Antiviral agents
WO2010085676A1 (en) 2009-01-22 2010-07-29 University Of Rochester Hybrid host materials for electrophosphorescent devices
KR20100087540A (ko) 2009-01-28 2010-08-05 삼성전자주식회사 잉크젯 기록용 잉크 조성물
CA2751458C (en) 2009-02-06 2018-06-05 Rfs Pharma, Llc Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
US20100240604A1 (en) 2009-03-20 2010-09-23 Alios Biopharma, Inc. Protected nucleotide analogs
WO2010108140A1 (en) 2009-03-20 2010-09-23 Alios Biopharma, Inc. Substituted nucleoside and nucleotide analogs
EP2264169A1 (en) 2009-06-15 2010-12-22 Qiagen GmbH Modified siNA
US20110212994A1 (en) 2009-06-26 2011-09-01 Brian Clem Small Molecule Choline Kinase Inhibitors, Screening Assays, and Methods for Safe and Effective Treatment of Neoplastic Disorders
US8927513B2 (en) 2009-07-07 2015-01-06 Alnylam Pharmaceuticals, Inc. 5′ phosphate mimics
CN102473843A (zh) 2009-08-04 2012-05-23 三菱化学株式会社 光电转换元件及使用该元件的太阳能电池
IN2012DN01254A (es) 2009-08-05 2015-05-15 Versitech Ltd
KR20120063515A (ko) 2009-09-09 2012-06-15 아빌라 테라퓨틱스, 인크. Ｐｉ３ 키나제 억제제 및 이들의 용도
US20120189670A1 (en) 2009-09-14 2012-07-26 Kirkpatrick D Lynn Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
JP5795766B2 (ja) 2009-09-21 2015-10-14 ギリード・サイエンシズ・インコーポレーテッド 抗ウイルス治療のための２′−フルオロ置換カルバ−ヌクレオシド類似体
US8455451B2 (en) 2009-09-21 2013-06-04 Gilead Sciences, Inc. 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
PL2480559T3 (pl) 2009-09-21 2013-11-29 Gilead Sciences Inc Sposoby i związki pośrednie do wytwarzania analogów 11cyjanokarbanukleozydowych
US20120264810A1 (en) 2009-09-22 2012-10-18 The University Of British Columbia Compositions and methods for enhancing cellular uptake and intracellular delivery of lipid particles
WO2011038207A1 (en) 2009-09-25 2011-03-31 Metabasis Therapeutics, Inc. Phosphorus-containing thyroid hormone receptor agonists and methods of use
DE102010035730A1 (de) 2009-09-28 2011-04-07 Merck Patent Gmbh Polymerisierbare Verbindungen und ihre Verwendung in Flüssigkristallanzeigen
US8871460B2 (en) 2009-11-09 2014-10-28 Neurogenetic Pharmaceuticals, Inc. Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor
CN102000103B (zh) 2009-12-21 2011-12-21 郑州大学 2’-氟-4’-叠氮-核苷类似物或其盐的药物应用
AR079980A1 (es) 2010-01-13 2012-03-07 Sanofi Aventis Derivados de oxazolopirimidina sustituida en 2,5,7
US9198972B2 (en) 2010-01-28 2015-12-01 Alnylam Pharmaceuticals, Inc. Monomers and oligonucleotides comprising cycloaddition adduct(s)
WO2011094890A1 (en) 2010-02-02 2011-08-11 Argusina Inc. Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
WO2011109799A1 (en) 2010-03-05 2011-09-09 Karyopharm Therapeutics, Inc. Nuclear transport modulatiors and uses thereof
AU2011232347B2 (en) 2010-03-24 2015-08-06 Musc Foundation For Research Development Compositions and methods for the treatment of degenerative diseases
WO2011146401A1 (en) 2010-05-17 2011-11-24 Intermune, Inc. Novel inhibitors of hepatitis c virus replication
FR2960235B1 (fr) 2010-05-18 2013-11-01 Inst Francais Du Petrole Procede d'oligomerisation des olefines utilisant une composition comprenant un complexe organometallique contenant un ligand alcoxy fonctionnalise par un hetero-atome.
FR2960234B1 (fr) 2010-05-18 2013-11-01 Inst Francais Du Petrole Procede de dimerisation de l'ethylene en butene-1 utilisant une composition comprenant un complexe a base de titane et un ligand alcoxy fonctionnalise par un hetero-atome.
TW201201815A (en) 2010-05-28 2012-01-16 Gilead Sciences Inc 1'-substituted-carba-nucleoside prodrugs for antiviral treatment
WO2011156632A2 (en) 2010-06-09 2011-12-15 Georgetown University Compositions and methods of treatment for tumors in the nervous system
US8614021B2 (en) 2010-06-10 2013-12-24 The United States Of America As Represented By The Secretary Of The Army Agents for enhanced charge transport across microbial membranes
SG186831A1 (en) 2010-07-19 2013-02-28 Gilead Sciences Inc Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
WO2012012776A1 (en) 2010-07-22 2012-01-26 Gilead Sciences, Inc. Methods and compounds for treating paramyxoviridae virus infections
CN102351931B (zh) 2010-09-07 2014-01-22 河南省科学院高新技术研究中心 嘧啶核苷衍生物、合成方法及其在制备抗肿瘤、抗病毒药物中的应用
TW201305185A (zh) 2010-09-13 2013-02-01 Gilead Sciences Inc 用於抗病毒治療之２’－氟取代之碳－核苷類似物
DE102010045369A1 (de) 2010-09-14 2012-03-15 Merck Patent Gmbh Materialien für organische Elektrolumineszenzvorrichtungen
CN103209987B (zh) 2010-09-22 2017-06-06 艾丽奥斯生物制药有限公司 取代的核苷酸类似物
US8877731B2 (en) 2010-09-22 2014-11-04 Alios Biopharma, Inc. Azido nucleosides and nucleotide analogs
US20120070411A1 (en) 2010-09-22 2012-03-22 Alios Biopharma, Inc. Substituted nucleotide analogs
US10000752B2 (en) 2010-11-18 2018-06-19 Curna, Inc. Antagonat compositions and methods of use
EP2646453A1 (en) 2010-11-30 2013-10-09 Gilead Pharmasset LLC Compounds
WO2012083048A2 (en) 2010-12-15 2012-06-21 Abbott Laboratories Anti-viral compounds
US20130273005A1 (en) 2010-12-20 2013-10-17 Gilead Sciences, Inc. Methods for treating hcv
US8772474B2 (en) 2010-12-22 2014-07-08 Alios Biopharma, Inc. Cyclic nucleotide analogs
WO2012088438A1 (en) 2010-12-22 2012-06-28 Eutropics Pharmaceuticals, Inc. Compositions and methods useful for treating diseases
TWI450891B (zh) 2010-12-29 2014-09-01 Dev Center Biotechnology 新穎微管蛋白抑制劑
CN103717222A (zh) 2011-02-24 2014-04-09 浙江大学 桥二硫二氧代哌嗪及其在治疗癌症方面的用途
KR20190060879A (ko) 2011-03-02 2019-06-03 제롬 쉔타그 단독으로 또는 c형 간염 바이러스 감염과 결합되는 간 지방증의 치료를 위한 조성물, 방법 및 진단
EP2966061B1 (en) 2011-03-04 2017-05-03 Life Technologies Corporation Compounds and methods for conjugation of biomolecules
JP2014508183A (ja) 2011-03-16 2014-04-03 エフ．ホフマン−ラ ロシュ アーゲー ６，５−複素環式プロパルギルアルコール化合物及びこれらの使用
JP2012216832A (ja) 2011-03-30 2012-11-08 Mitsubishi Chemicals Corp 光電変換素子、太陽電池、太陽電池モジュール及びインク
WO2012139028A2 (en) 2011-04-06 2012-10-11 The Trustees Of Princeton University Anti-viral combination therapy
US8877733B2 (en) 2011-04-13 2014-11-04 Gilead Sciences, Inc. 1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment
EP2697242B1 (en) 2011-04-13 2018-10-03 Merck Sharp & Dohme Corp. 2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
WO2012142085A1 (en) 2011-04-13 2012-10-18 Merck Sharp & Dohme Corp. 2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
GB201108825D0 (en) 2011-05-25 2011-07-06 Univ Dundee Morpholino compounds, uses and methods
US20130018011A1 (en) 2011-06-10 2013-01-17 Hassan Javanbakht Method of treating dengue fever
JP2014520772A (ja) 2011-06-30 2014-08-25 ステラ・アンパルトセルスカブ Ｈｃｖ併用療法
FR2977586B1 (fr) 2011-07-08 2013-07-12 Rhodia Operations Procede de fabrication de composes comprenant des fonctions nitriles
WO2013033270A2 (en) 2011-08-29 2013-03-07 Coferon, Inc. Bromodomain ligands capable of dimerizing in an aqueous solution, and methods of using same
JP6054967B2 (ja) 2011-09-02 2016-12-27 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 置換アネレート化ピリミジンおよびその使用
CN102286047A (zh) 2011-09-14 2011-12-21 郑州大学 2’-脱氧-2’-氟-4’-三氮唑取代-β-D胞苷类似物、其制备方法及其应用
CA2847355A1 (en) 2011-09-16 2013-03-21 Abbvie Inc. Methods for treating hcv
KR20190075142A (ko) 2011-09-16 2019-06-28 길리애드 파마셋 엘엘씨 Hcv 치료 방법
US8575119B2 (en) 2011-09-23 2013-11-05 Enanta Pharmaceuticals, Inc. 2′-chloroacetylenyl substituted nucleoside derivatives
SG11201401499XA (en) 2011-10-14 2014-09-26 Stc Unm Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
FR2982858B1 (fr) 2011-11-18 2013-11-29 Rhodia Operations Procede de fabrication de composes comprenant des fonctions nitriles
WO2013090420A2 (en) 2011-12-12 2013-06-20 Catabasis Pharmaceuticals, Inc. Fatty acid antiviral conjugates and their uses
FR2984322B1 (fr) 2011-12-16 2013-12-20 Rhodia Operations Procede de fabrication de composes comprenant des fonctions nitriles
SI2794627T1 (sl) 2011-12-22 2019-02-28 Alios Biopharma, Inc. Substituirani nukleozidi, nukleotidi in njihovi analogi
EP2794630A4 (en) 2011-12-22 2015-04-01 Alios Biopharma Inc SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE
US20130172240A1 (en) 2011-12-28 2013-07-04 Abbvie Inc. Methods for treating hcv
CN102603836A (zh) 2012-02-10 2012-07-25 郑州大学 五味子丙素简化物、类似物及其制备方法和应用
EP2834258B1 (en) 2012-03-13 2017-01-04 Gilead Sciences, Inc. 2'- substituted carba-nucleoside analogs for antiviral treatment
TWI635111B (zh) 2012-03-16 2018-09-11 馬克專利公司 共軛聚合物
WO2013142124A1 (en) 2012-03-21 2013-09-26 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
WO2013142159A1 (en) 2012-03-21 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
MX361460B (es) 2012-03-21 2018-12-06 Alios Biopharma Inc Nucleosidos sustituidos, nucleotidos y analogos de los mismos.
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
CN104204009B (zh) 2012-03-29 2016-08-17 英派尔科技开发有限公司 二氧杂硼烷共聚物及其应用
WO2013151975A1 (en) 2012-04-02 2013-10-10 Northeastern University Compositions and methods for the inhibition of methyltransferases
JP2013237721A (ja) 2012-05-11 2013-11-28 Nitto Denko Corp 再剥離用水分散型アクリル系粘着剤組成物、及び粘着シート
CN104380493A (zh) 2012-06-04 2015-02-25 默克专利有限公司 有机半导体
WO2014005125A2 (en) 2012-06-29 2014-01-03 Biotium, Inc. Fluorescent compounds and uses thereof
KR20150027155A (ko) 2012-07-03 2015-03-11 브리스톨-마이어스 스큅 컴퍼니 바이러스 감염의 치료를 위한 뉴클레오시드 화합물의 부분입체이성질체적으로 풍부한 포스포르아미데이트 유도체의 제조 방법
US9682958B2 (en) 2012-07-23 2017-06-20 Merck Patent Gmbh Ligands and their preparation
US20140038991A1 (en) 2012-08-06 2014-02-06 Astar Biotech Llc Protein Kinase Inhibitors
WO2014026198A1 (en) 2012-08-10 2014-02-13 Epizyme, Inc. Inhibitors of protein methyltransferase dot1l and methods of use thereof
WO2014031872A2 (en) 2012-08-23 2014-02-27 The Broad Institute, Inc. Small molecule inhibitors for treating parasitic infections
WO2014035140A2 (en) 2012-08-30 2014-03-06 Kainos Medicine, Inc. Compounds and compositions for modulating histone methyltransferase activity
EP2712868A1 (en) 2012-09-28 2014-04-02 B. Braun Melsungen AG 5-Fluoruoracil Derivatives
AP2015008384A0 (en) 2012-10-08 2015-04-30 Univ Montpellier Ct Nat De La Rech Scient 2'-Chloro nucleoside analogs for hcv infection
DE102012109685A1 (de) 2012-10-11 2014-04-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Umwandlung reaktiver Gruppen an Si-C-gebundenen Resten von Silanen unter gleichzeitiger Vergrößerung von deren räumlichem Abstand zueinander
US9457039B2 (en) 2012-10-17 2016-10-04 Merck Sharp & Dohme Corp. 2′-disubstituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
EP2909209B1 (en) 2012-10-17 2022-08-03 Merck Sharp & Dohme LLC 2'-cyano substituted nucleoside derivatives and methods of use thereof for treatment of viral diseases
KR20120135501A (ko) 2012-10-29 2012-12-14 에스에프씨 주식회사 축합환 화합물 및 이를 포함한 유기 발광 소자
US9644145B2 (en) 2012-12-14 2017-05-09 Merck Patent Gmbh Birefringent RM lens
HK1216535A1 (zh) 2012-12-21 2016-11-18 Alios Biopharma, Inc. 取代的核苷、核苷酸及其類似物
GEP201706757B (en) 2012-12-21 2017-10-25 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
FR2999917B1 (fr) 2012-12-26 2017-06-23 Oreal Polymere a empreinte moleculaire pour pieger selectivement les molecules odorantes
US20140200215A1 (en) 2013-01-15 2014-07-17 Intermune, Inc. Lysophosphatidic acid receptor antagonists
JP6024479B2 (ja) 2013-01-28 2016-11-16 コニカミノルタ株式会社 光学フィルム、円偏光板および画像表示装置
EP2953950B1 (en) 2013-02-11 2021-01-13 The Regents of The University of California Compositions and methods for treating neurodegenerative diseases
WO2014134127A1 (en) 2013-02-26 2014-09-04 Northeastern University Cannabinergic nitrate esters and related analogs
TW201526899A (zh) 2013-02-28 2015-07-16 Alios Biopharma Inc 醫藥組成物
WO2014164533A1 (en) 2013-03-11 2014-10-09 Vertex Pharmaceuticals Incorporated Methods of stereoselective synthesis of substituted nucleoside analogs
US9790291B2 (en) 2013-03-14 2017-10-17 Formosa Plastics Corporation, Usa Non-phthalate compounds as electron donors for polyolefin catalysts
MX380146B (es) 2013-03-15 2025-03-12 Celgene Car Llc Inhibidores mk2 y usos de los mismos.
JP6329764B2 (ja) 2013-03-15 2018-05-23 信越化学工業株式会社 対称ハイパーブランチ型シリコーン変性重合性化合物、及びそのモジュール化した製造方法
TW201542578A (zh) 2013-06-26 2015-11-16 Alios Biopharma Inc 經取代之核苷、核苷酸及其類似物
WO2015003146A1 (en) 2013-07-03 2015-01-08 Georgetown University Boronic acid derivatives of resveratrol for activating deacetylase enzymes
AU2014287471C1 (en) 2013-07-10 2019-11-28 Vertex Pharmaceuticals Incorporated Fused piperidine amides as modulators of ion channels
CN104086612A (zh) 2013-07-17 2014-10-08 郑州大学 4-取代胺基-2′-脱氧-2′-氟-4′-叠氮-β-D-胞苷类核苷化合物、制备方法及其应用
WO2015016187A1 (ja) 2013-07-29 2015-02-05 富士フイルム株式会社 非水二次電池用電解液および非水二次電池
SG11201601199QA (en) 2013-08-19 2016-03-30 Univ Kingston Carbene-functionalized composite materials
AU2014312227A1 (en) 2013-08-29 2016-04-21 Baylor College Of Medicine Compositions and methods for the treatment of metabolic and body weight related disorders
SI3043803T1 (sl) 2013-09-11 2022-09-30 Emory University Nukleotidne in nukleozidne sestave in njihova uporaba
US20160257657A1 (en) 2013-09-20 2016-09-08 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
KR101628288B1 (ko) 2013-09-30 2016-06-08 주식회사 엘지화학 음성 광학 분산도를 갖는 광학 소자 제조용 조성물 및 이로부터 제조된 광학 이방체
US10385088B2 (en) 2013-10-02 2019-08-20 Modernatx, Inc. Polynucleotide molecules and uses thereof
SG11201602595TA (en) 2013-10-11 2016-04-28 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
CN105658219A (zh) 2013-10-25 2016-06-08 艾伯维公司 用于治疗hcv的方法
UA119050C2 (uk) 2013-11-11 2019-04-25 Ґілеад Саєнсиз, Інк. ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ
US20150167017A1 (en) 2013-12-13 2015-06-18 Moderna Therapeutics, Inc. Alternative nucleic acid molecules and uses thereof
CN103709220B (zh) 2014-01-13 2016-02-17 河南省科学院高新技术研究中心 3-甲基尿苷及4-甲基胞苷核苷类化合物、合成方法及其药物用途
EP2896678B1 (en) 2014-01-21 2018-10-17 Merck Patent GmbH Liquid crystal display
JP6581100B2 (ja) 2014-02-06 2019-09-25 リボサイエンス・エルエルシー インフルエンザｒｎａ複製の阻害剤としての４’−ジフルオロメチル置換ヌクレオシド誘導体
JP6144215B2 (ja) 2014-02-07 2017-06-07 富士フイルム株式会社 光電変換素子およびその使用方法、光センサ、並びに、撮像素子
KR101724348B1 (ko) 2014-02-27 2017-04-07 디아이씨 가부시끼가이샤 액정 표시 장치
EP3730590B1 (de) 2014-03-10 2025-12-24 Merck Patent GmbH Flüssigkristalline medien mit homöotroper ausrichtung
EP3122729A4 (en) 2014-03-28 2017-11-15 Calitor Sciences, LLC Substituted heteroaryl compounds and methods of use
WO2015143712A1 (en) 2014-03-28 2015-10-01 Merck Sharp & Dohme Corp. 4'-substituted nucleoside reverse transcriptase inhibitors
WO2015160251A1 (en) 2014-04-15 2015-10-22 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno New anti-clostridium compounds
WO2015196128A2 (en) 2014-06-19 2015-12-23 Moderna Therapeutics, Inc. Alternative nucleic acid molecules and uses thereof
US20170175129A1 (en) 2014-06-19 2017-06-22 Moderna Therapeutics, Inc. Alternative nucleic acid molecules and uses thereof
WO2015196118A1 (en) 2014-06-19 2015-12-23 Moderna Therapeutics, Inc. Alternative nucleic acid molecules and uses thereof
WO2015198915A1 (ja) 2014-06-23 2015-12-30 Dic株式会社 重合性液晶組成物及び該組成物を用いて作製した光学異方体、位相差膜、位相差パターニング膜
CN106573011A (zh) 2014-06-24 2017-04-19 艾丽奥斯生物制药有限公司 取代的核苷、核苷酸和其类似物
US9603863B2 (en) 2014-06-24 2017-03-28 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
JP5888480B1 (ja) 2014-07-15 2016-03-22 Dic株式会社 液晶表示装置
TWI678369B (zh) 2014-07-28 2019-12-01 美商基利科學股份有限公司 用於治療呼吸道合胞病毒感染之噻吩並［３,２-ｄ］嘧啶、呋喃並［３,２-ｄ］嘧啶及吡咯並［３,２-ｄ］嘧啶化合物類
KR102289820B1 (ko) 2014-08-01 2021-08-17 삼성전자주식회사 축합환 화합물 및 이를 포함한 유기 발광 소자
US9920242B2 (en) 2014-08-22 2018-03-20 Arizona Board Of Regents On Behalf Of Arizona State University Metal-assisted delayed fluorescent materials as co-host materials for fluorescent OLEDs
EP2990461B1 (en) 2014-08-25 2018-09-19 Merck Patent GmbH Liquid crystal medium
JP6326140B2 (ja) 2014-08-27 2018-05-16 富士フイルム株式会社 化合物、組成物、膜、光学機器
EP3194414A1 (en) 2014-09-15 2017-07-26 Medivir Ab Methods for the preparation of diastereomerically pure phosphoramidate prodrugs
WO2016066582A1 (en) 2014-10-28 2016-05-06 Bci Pharma Nucleoside kinase inhibitors
TWI767201B (zh) 2014-10-29 2022-06-11 美商基利科學股份有限公司 絲狀病毒科病毒感染之治療
EP3212658A4 (en) 2014-10-31 2018-07-25 Cocrystal Pharma, Inc. 2',2'-dihalo nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
US20170343847A1 (en) 2014-11-06 2017-11-30 Merck Patent Gmbh Light modulation element
JP2017535646A (ja) 2014-11-11 2017-11-30 メルク・パテント・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ ＧｍｂＨ ビメソゲン化合物及びメソゲン媒体
CN105646629A (zh) 2014-11-25 2016-06-08 广州市恒诺康医药科技有限公司 L-核苷类化合物及其应用
CN105777580B (zh) 2014-12-18 2018-05-18 湖南化工研究院有限公司 酰基乙腈类化合物及其制备方法与应用
MA41441A (fr) 2014-12-19 2017-12-12 Alios Biopharma Inc Nucléosides substitués, nucléotides et analogues de ceux-ci
CN107003578B (zh) 2014-12-19 2021-03-23 默克专利股份有限公司 光调制元件
MA41213A (fr) 2014-12-19 2017-10-24 Alios Biopharma Inc Nucléosides substitués, nucléotides et analogues de ceux-ci
CN107109223B (zh) 2014-12-30 2021-03-23 默克专利股份有限公司 双介晶化合物和介晶介质
US20160237106A1 (en) 2015-01-14 2016-08-18 Riboscience Llc 4'-azido substituted nucleoside derivatives as inhibitors of ebola virus rna replication
EP3247767B1 (de) 2015-01-20 2018-12-26 cynora GmbH Organische moleküle, insbesondere zur verwendung in optoelektronischen bauelementen
KR20170107436A (ko) 2015-01-20 2017-09-25 제이엔씨 주식회사 액정 조성물 및 액정 표시 소자
EP3048159B1 (en) 2015-01-22 2019-08-07 Merck Patent GmbH Liquid crystal medium
KR20170104618A (ko) 2015-01-23 2017-09-15 메르크 파텐트 게엠베하 광 변조 소자
EP3248060B1 (en) 2015-01-23 2020-09-02 Merck Patent GmbH Light modulation element
KR102539268B1 (ko) 2015-02-10 2023-06-07 메르크 파텐트 게엠베하 액정 매질
JP6485106B2 (ja) 2015-02-24 2019-03-20 Jnc株式会社 液晶組成物および液晶表示素子
WO2016145142A1 (en) 2015-03-10 2016-09-15 Emory University Nucleotide and nucleoside therapeutics compositions and uses related thereto
KR20160110900A (ko) 2015-03-13 2016-09-22 메르크 파텐트 게엠베하 액정 매질
KR102587314B1 (ko) 2015-03-13 2023-10-12 메르크 파텐트 게엠베하 액정 매질
WO2016148170A1 (ja) 2015-03-17 2016-09-22 富士フイルム株式会社 有機半導体組成物、及び、有機半導体素子の製造方法
KR20170131399A (ko) 2015-03-24 2017-11-29 제이엔씨 주식회사 액정 조성물 및 액정 표시 소자
US20180271873A1 (en) 2015-04-01 2018-09-27 The California Institute For Biomedical Research Methods for treating viral infections
FR3034767A1 (fr) 2015-04-07 2016-10-14 Centre Nat Rech Scient Reduction des fonctions carbonyles de glucides et derives de glucides en milieu aqueux par le dithionite de sodium
JPWO2016170948A1 (ja) 2015-04-23 2018-02-15 Jnc株式会社 液晶組成物および液晶表示素子
WO2016172631A2 (en) 2015-04-24 2016-10-27 President And Fellows Of Harvard College Substrate selective inhibitors of insulin-degrading enzyme (ide) and uses thereof
CN107709344B (zh) 2015-05-01 2022-07-15 共晶制药股份有限公司 用于治疗黄病毒科病毒和癌症的核苷类似物
CN106279322B (zh) 2015-05-15 2019-07-30 上海唐润医药科技有限公司 抗丙肝病毒的核苷类化合物及其应用
DE102015210388A1 (de) 2015-06-05 2016-12-08 Siemens Aktiengesellschaft Organische Heterozyklische Alkalimetallsalze als n-Dotierstoffe in der Organischen Elektronik
AU2016289413B2 (en) 2015-07-06 2020-03-26 Bayer Cropscience Aktiengesellschaft Nitrogenous heterocycles as a pesticide
WO2017019817A1 (en) 2015-07-29 2017-02-02 Medivation Technologies, Inc. Methods and compositions for targeted therapeutics
WO2017019822A1 (en) 2015-07-29 2017-02-02 Medivation Technologies, Inc. Pellet composition containing repair cells
WO2017019830A1 (en) 2015-07-29 2017-02-02 Medivation Technologies, Inc. Methods and compositions for targeted therapeutics
EP3331530A4 (en) 2015-08-03 2018-12-19 Raze Therapeutics Inc. Mthfd2 inhibitors and uses thereof
MX2018001073A (es) 2015-08-06 2018-06-12 Chimerix Inc Nucleosidos de pirrolopirimidina y analogos de los mismos utiles como agentes antivirales.
WO2017027645A1 (en) 2015-08-13 2017-02-16 Merck Sharp & Dohme Corp. Cyclic di-nucleotide compounds as sting agonists
TWI870767B (zh) 2015-08-26 2025-01-21 比利時商健生藥品公司 使用作為prmt5抑制劑之新穎經6-6雙環芳香環取代之核苷類似物
WO2017041893A1 (en) 2015-09-09 2017-03-16 Merck Patent Gmbh Liquid-crystalline medium
CN106518766A (zh) 2015-09-11 2017-03-22 中国人民解放军军事医学科学院毒物药物研究所 新型二芳基脲类化合物,其制备方法及其医药用途
CN106518767A (zh) 2015-09-11 2017-03-22 中国人民解放军军事医学科学院毒物药物研究所 取代苯并吡唑二芳基脲类化合物,其制备方法及其医药用途
CN108026448B (zh) 2015-09-15 2022-01-04 默克专利股份有限公司 具有垂面配向的液晶介质
EP4088718A1 (en) 2015-09-16 2022-11-16 Gilead Sciences, Inc. Methods for treating coronaviridae virus infections
CN105254624B (zh) 2015-09-18 2019-08-09 上海吉铠医药科技有限公司 异噻唑衍生物pim激酶抑制剂及其制备方法与在制药中的应用
CN105130959B (zh) 2015-09-18 2018-08-03 上海吉铠医药科技有限公司 嘧啶衍生物pim激酶抑制剂及其制备方法与在制药中的应用
CN105218523B (zh) 2015-09-18 2019-08-23 上海吉铠医药科技有限公司 吡啶衍生物pim激酶抑制剂及其制备方法与在制药中的应用
US10875842B2 (en) 2015-09-28 2020-12-29 Araxes Pharma Llc Inhibitors of KRAS G12C mutant proteins
RU2768621C1 (ru) 2015-09-30 2022-03-24 Вертекс Фармасьютикалз Инкорпорейтед Способ лечения рака с использованием комбинации повреждающих днк средств и ингибиторов atr
WO2017066797A1 (en) 2015-10-16 2017-04-20 Modernatx, Inc. Trinucleotide mrna cap analogs
WO2017066782A1 (en) 2015-10-16 2017-04-20 Modernatx, Inc. Hydrophobic mrna cap analogs
WO2017066791A1 (en) 2015-10-16 2017-04-20 Modernatx, Inc. Sugar substituted mrna cap analogs
AU2016340183A1 (en) 2015-10-16 2018-04-19 Modernatx, Inc. mRNA cap analogs and methods of mRNA capping
US20190218546A1 (en) 2015-10-16 2019-07-18 Modernatx, Inc. Mrna cap analogs with modified phosphate linkage
WO2017068875A1 (ja) 2015-10-23 2017-04-27 Jnc株式会社 液晶組成物および液晶表示素子
WO2017073933A1 (ko) 2015-10-26 2017-05-04 주식회사 엘지화학 스피로형 화합물 및 이를 포함하는 유기 발광 소자
CN107108498B (zh) 2015-10-26 2020-08-21 株式会社Lg化学 胺化合物和包含其的有机发光元件
WO2017073931A1 (ko) 2015-10-28 2017-05-04 주식회사 엘지화학 스피로형 화합물 및 이를 포함하는 유기 발광 소자
EA201891235A1 (ru) 2015-11-25 2018-12-28 Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния Составы лекарственных средств для лечения злокачественной опухоли
KR20180084138A (ko) 2015-12-03 2018-07-24 바이엘 크롭사이언스 악티엔게젤샤프트 살곤충제로서의 메소이온성 할로겐화 3-(아세틸)-1-[(1,3-티아졸-5-일)메틸]-1h-이미다조[1,2-a]피리딘-4-윰-2-올레이트 유도체 및 관련 화합물
KR20180093956A (ko) 2015-12-11 2018-08-22 메르크 파텐트 게엠베하 중합가능 화합물 및 이의 액정 디스플레이에서의 용도
CN106892920B (zh) 2015-12-18 2019-12-13 中国医学科学院医药生物技术研究所 苦豆碱衍生物、其制备方法及用途
KR102419178B1 (ko) 2015-12-29 2022-07-11 삼성디스플레이 주식회사 유기 발광 소자
TWI740910B (zh) 2016-03-09 2021-10-01 美商艾洛斯生物製藥公司 非環抗病毒劑
KR20180116307A (ko) 2016-03-10 2018-10-24 얀센 파마슈티카 엔.브이. Prmt5 저해제로 사용하기 위한 치환 뉴클레오사이드 유사체
WO2017161028A1 (en) 2016-03-16 2017-09-21 Kura Oncology, Inc. Substituted inhibitors of menin-mll and methods of use
US11963972B2 (en) 2016-03-23 2024-04-23 Emory University Antiviral agents and nucleoside analogs for treatment of Zika virus
CN107286190A (zh) 2016-04-13 2017-10-24 刘沛 核苷之烃氧基苄基氨基磷酸/膦酸酯衍生物的制备及其医药用途
WO2017184668A1 (en) 2016-04-20 2017-10-26 Gilead Sciences, Inc. Methods for treating flaviviridae virus infections
GB201609600D0 (en) 2016-06-01 2016-07-13 Nucuna Biomed Ltd Cancer treatments
WO2017205980A1 (en) 2016-06-01 2017-12-07 Greencentre Canada Etching metal using n-heterocyclic carbenes
WO2018009623A1 (en) 2016-07-08 2018-01-11 Atea Pharmaceuticals, Inc. β-D-2'-DEOXY-2'-SUBSTITUTED-4'-SUBSTITUTED-2-SUBSTITUTED-N6-SUBSTITUTED-6-AMINOPURINE NUCLEOTIDES FOR THE TREATMENT OF PARAMYXOVIRUS AND ORTHOMYXOVIRUS INFECTIONS
JP2019527381A (ja) 2016-07-20 2019-09-26 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 光学スイッチ素子において使用するためのスイッチ層
JP2019524795A (ja) 2016-08-12 2019-09-05 ヤンセン バイオファーマ インク． 置換ヌクレオシド、ヌクレオチド、及びそのアナログ
JP2018044028A (ja) 2016-09-12 2018-03-22 オルガノサイエンス株式会社 液晶組成物
EP3519399A1 (en) 2016-10-03 2019-08-07 Sigilon Therapeutics, Inc. Compounds, devices, and uses thereof
US11196005B2 (en) 2016-10-05 2021-12-07 Raynergy Tek Incorporation Organic semiconducting compounds
US10858344B2 (en) 2016-11-23 2020-12-08 Cv6 Therapeutics (Ni) Limited Hydantoin containing deoxyuridine triphosphatase inhibitors
WO2018106820A1 (en) 2016-12-07 2018-06-14 Kura Oncology, Inc. Methods of promoting beta cell proliferation
WO2018106818A1 (en) 2016-12-07 2018-06-14 Kura Oncology, Inc. Methods of promoting beta cell proliferation
JP6551618B2 (ja) 2016-12-16 2019-07-31 Dic株式会社 表示素子用封止材料組成物、及び、それを用いた表示素子
JP6547912B2 (ja) 2016-12-19 2019-07-24 Dic株式会社 重合性組成物、及び、それを用いた光学異方体
US20180177784A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Heterocyclic compounds as immunomodulators
WO2018138685A2 (en) 2017-01-27 2018-08-02 Janssen Biotech, Inc. Cyclic dinucleotides as sting agonists
US12089486B2 (en) 2017-02-08 2024-09-10 Universal Display Corporation Organic electroluminescent materials and devices
CN116036112A (zh) 2017-03-14 2023-05-02 吉利德科学公司 治疗猫冠状病毒感染的方法
US11944627B2 (en) 2017-03-24 2024-04-02 Kura Oncology, Inc. Methods for treating hematological malignancies and Ewing's sarcoma
EP3600273A4 (en) 2017-03-31 2021-01-20 Peloton Therapeutics, Inc. CD73 INHIBITORS AND USES THEREOF
PL3611174T3 (pl) 2017-04-07 2022-08-08 Medshine Discovery Inc. Pochodne [1,2,4]triazolo[1,5-c]pirymidyny jako inhibitor receptora a2a
WO2018189134A1 (de) 2017-04-13 2018-10-18 Merck Patent Gmbh Zusammensetzung für organische elektronische vorrichtungen
KR20190141747A (ko) 2017-05-01 2019-12-24 길리애드 사이언시즈, 인코포레이티드 (S)-2-에틸부틸 2-(((S)-(((2R,3S,4R,5R)-5-(4-아미노피롤로[2,1-f] [1,2,4]트리아진-7-일)-5-시아노-3,4-디히드록시테트라히드로푸란-2-일)메톡시)(페녹시) 포스포릴)아미노)프로파노에이트의 결정질 형태
US11466047B2 (en) 2017-05-12 2022-10-11 Merck Sharp & Dohme Llc Cyclic di-nucleotide compounds as sting agonists
WO2018213185A1 (en) 2017-05-17 2018-11-22 Drexel University Rela inhibitors for biofilm disruption
BR112019024652A2 (pt) 2017-05-25 2020-06-09 Hyconix Inc processo para converter um alcano em um alceno
US10004719B1 (en) 2017-05-30 2018-06-26 Taigen Biotechnology Co., Ltd. Solid dispersion formulation
CN110958880B (zh) 2017-05-30 2023-08-08 东莞东阳光太景医药研发有限责任公司 固体分散制剂
GB2577652A (en) 2017-05-31 2020-04-01 Commw Scient Ind Res Org Inhibiting hydrocarbon hydrate agglomeration
JP2018203945A (ja) 2017-06-08 2018-12-27 Dic株式会社 重合性液晶組成物、及び、それを用いた光学異方体
WO2018226976A1 (en) 2017-06-08 2018-12-13 Kura Oncology, Inc. Methods and compositions for inhibiting the interaction of menin with mll proteins
US11718638B2 (en) 2017-06-21 2023-08-08 Wave Life Sciences Ltd. Compounds, compositions and methods for synthesis
US10675296B2 (en) 2017-07-11 2020-06-09 Gilead Sciences, Inc. Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections
US11548893B2 (en) 2017-07-15 2023-01-10 Arisan Therapeutics Inc. Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection
PL3678668T3 (pl) 2017-09-08 2024-06-03 The Board Of Trustees Of The Leland Stanford Junior University Inhibitory enpp1 i ich zastosowanie w leczeniu nowotworu
WO2019052935A1 (en) 2017-09-13 2019-03-21 Merck Patent Gmbh ORGANIC SEMICONDUCTOR COMPOUNDS
WO2019053696A1 (en) 2017-09-18 2019-03-21 Alios Biopharma, Inc. SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
KR20190041918A (ko) 2017-10-13 2019-04-23 메르크 파텐트 게엠베하 액정 매질
EP3700527A4 (en) 2017-10-25 2021-03-10 Children's Medical Center Corporation PAPD5 INHIBITORS AND METHOD OF USING THEM
US11649321B2 (en) 2017-11-02 2023-05-16 Raynergy Tek Incorporation Organic semiconducting compounds
CN109748944B (zh) 2017-11-03 2021-12-10 中国科学院上海药物研究所 5’-脱氧-5’-异丙基取代氨基核苷类化合物、其制备方法和用途
CN109748921B (zh) 2017-11-03 2022-03-22 中国科学院上海药物研究所 N-叔丁氧羰基保护的杂环类化合物、其制备方法及其用于制备c-核苷类似物的方法
CN109748943A (zh) 2017-11-03 2019-05-14 中国科学院上海药物研究所 2’-c-甲基取代核苷类化合物及其制备与用途
WO2019092171A1 (en) 2017-11-09 2019-05-16 Inflazome Limited Novel sulfonamide carboxamide compounds
KR102677284B1 (ko) 2017-11-16 2024-06-24 제이에스알 가부시끼가이샤 레지스트 하층막 형성용 조성물, 레지스트 하층막 및 그의 형성 방법, 패터닝된 기판의 제조 방법 그리고 화합물
EP3502209B1 (en) 2017-12-20 2020-10-14 Merck Patent GmbH Liquid-crystalline media having homeotropic alignment
EP3727401A4 (en) 2017-12-20 2022-04-06 Merck Sharp & Dohme Corp. CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS
EP3502210B1 (en) 2017-12-20 2020-09-09 Merck Patent GmbH Liquid-crystal medium
KR20190076339A (ko) 2017-12-22 2019-07-02 한미약품 주식회사 신규한 2,6-나프티리딘 2-옥시드 유도체 화합물 및 이의 용도
MX2020006864A (es) 2017-12-27 2020-11-11 Univ Emory Modalidades combinadas para inhibidores de nucleosidos y/o nadph oxidasa (nox) como agentes antivirales especificos de mieloides.
CN111094317B (zh) 2017-12-29 2023-03-31 上海和誉生物医药科技有限公司 一种具有cd73抑制活性的膦酸衍生物、其制备方法和应用
JP2019137753A (ja) 2018-02-08 2019-08-22 シャープ株式会社 液晶組成物および液晶ディスプレイ
WO2019154956A1 (en) 2018-02-08 2019-08-15 Enyo Pharma Non-fused thiophene derivatives and their uses
EP3761993A4 (en) 2018-03-09 2022-03-09 Arcus Biosciences, Inc. PARENTERALLY ADMINISTRATED IMMUNE-ENHANCERING DRUGS
CN108276352B (zh) 2018-03-13 2022-09-20 华东理工大学 一种具有杀线虫活性的含氮杂环化合物及其制法和用途
US20210145889A1 (en) 2018-04-04 2021-05-20 Sigilon Therapeutics, Inc. Methods, compositions, and implantable elements comprising stem cells
WO2019215076A1 (de) 2018-05-08 2019-11-14 Bayer Aktiengesellschaft Verfahren zur herstellung stickstoffhaltiger heterocyclen
CN108727344A (zh) 2018-05-14 2018-11-02 嘉兴特科罗生物科技有限公司 一种化合物及其合成方法和应用
US11945803B2 (en) 2018-08-07 2024-04-02 Tosk, Inc. Modulators of RAS GTPase
JP7025064B2 (ja) 2018-08-09 2022-02-24 ヤマサ醤油株式会社 ４’－置換ヌクレオシド誘導体の立体選択的合成法
CN110215456A (zh) 2019-06-25 2019-09-10 华中农业大学 一种由gc376与gs-441524组成的猫冠状病毒抑制剂组合物
CN110330540A (zh) 2019-08-08 2019-10-15 木天(济南)生物科技有限公司 核苷盐及其制备方法
CN110724174B (zh) 2019-09-10 2021-02-05 广州六顺生物科技股份有限公司 吡咯并三嗪类化合物、组合物及其应用
CN110776512A (zh) 2019-11-28 2020-02-11 成都傲飞生物化学品有限责任公司 一种核苷类似物的制备方法
TWI775313B (zh) 2020-02-18 2022-08-21 美商基利科學股份有限公司 抗病毒化合物
TWI883391B (zh) 2020-02-18 2025-05-11 美商基利科學股份有限公司 抗病毒化合物
TWI791193B (zh) 2020-02-18 2023-02-01 美商基利科學股份有限公司 抗病毒化合物
CN111620909B (zh) 2020-06-05 2022-12-02 广东中科药物研究有限公司 一种瑞德西韦的前体药物及其制备方法与应用

Also Published As

Publication number Publication date
PT4106876T (pt) 2025-11-13
AU2021224588B2 (en) 2024-07-18
EP4644394A2 (en) 2025-11-05
WO2021168004A1 (en) 2021-08-26
AU2021224588A1 (en) 2022-08-25
KR20220143064A (ko) 2022-10-24
EP4106876B1 (en) 2025-09-17
TWI777411B (zh) 2022-09-11
US20210292348A1 (en) 2021-09-23
US12030903B2 (en) 2024-07-09
TW202140038A (zh) 2021-11-01
CN115135383B (zh) 2024-06-11
US20250002513A1 (en) 2025-01-02
JP7429799B2 (ja) 2024-02-08
CN115135383A (zh) 2022-09-30
JP2023514182A (ja) 2023-04-05
KR20250133471A (ko) 2025-09-05
JP2024045349A (ja) 2024-04-02
AU2024227286A1 (en) 2024-10-31
SI4106876T1 (sl) 2025-11-28
CA3171648A1 (en) 2021-08-26
ES3052691T3 (en) 2026-01-13
CN118598916A (zh) 2024-09-06
EP4106876A1 (en) 2022-12-28

Similar Documents

Publication Publication Date Title
AR121356A1 (es) Compuestos antivirales
AR121355A1 (es) Compuestos antivirales
AR121044A1 (es) Inhibidores de egfr
AR110935A1 (es) Derivados de pirrolo[1,2-b]piridazina
AR122902A2 (es) Compuestos terapéuticamente activos y sus métodos de preparación
AR097082A1 (es) Compuestos terapéuticamente activos y sus métodos de uso
AR119010A1 (es) Compuestos, composiciones y métodos de uso
AR118374A1 (es) Inhibidores de la proteína tirosina fosfatasa y métodos para usarlos
AR110405A1 (es) Compuestos
AR105845A1 (es) Compuestos de heteroarilo bicíclicos fusionados como moduladores de la función irak4
AR091976A1 (es) Inhibidores de proteasa ns3 de vhc
AR119057A1 (es) Compuestos de 1-oxo-isoindolin-5-carboxamida sustituida, composiciones de estos y métodos de tratamiento con dichos compuestos
AR094990A1 (es) Derivados de amida y su uso para el tratamiento de infección por vih
AR099498A1 (es) Compuestos de triazina y su uso farmacéutico
AR110789A1 (es) Compuestos moduladores del receptor de hidrocarburos de arilo (ahr)
AR087792A1 (es) Compuestos heterociclicos tetraciclicos y metodos para el uso de los mismos en el tratamiento de enfermedades virales
AR110790A1 (es) Compuestos moduladores del receptor de hidrocarburos de arilo (ahr)
AR087793A1 (es) Compuestos de benzofurano sustituido y metodos para el uso de los mismos en el tratamiento de enfermedades virales
AR098103A1 (es) Composiciones pesticidas y métodos relacionados
AR120868A1 (es) Tiofen-2-carboxamidas sustituidas y ácidos tiofen-2-carboxílicos sustituidos y sus derivados
AR113878A1 (es) Compuestos de biarilo sustituido como inhibidores de indolamina 2,3-dioxigenasa (ido)
AR122517A1 (es) Isoxazolidinas como inhibidores de ripk1 y usos de las mismas
AR109711A1 (es) Inhibidores de fosfatidilinositol 3-quinasa
AR119376A1 (es) Compuestos heterocíclicos
AR128440A1 (es) Inhibidores de cinasas raf